Resources

Past Presentation

Use of HCV Antivirals in Patients with Swallowing Difficulties | November 6, 2024

Date of Presentation: November 6, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #epclusa  #hcv  #hcv treatment  #hep c  #hepatitis  #mavyret  #medications  #swallowing  

In this presentation, Jessica Orizu, PharmD Candidate, will review the use of direct-acting antivirals (DAAs) in patients with swallowing difficulties, focusing on the use of sofosbuvir/velpatasvir (Epclusa) and glecaprevir/pibrentasvir (Mavyret). The discussion will include an in-depth analysis of the manufacturers’ recommendations, existing relevant clinical studies and case reports/series, and of national liver health guidelines.

Recording:

Presented by:

Jessica Orizu

Jessica Orizu, is a PharmD Candidate ’25 at the University of Michigan College of Pharmacy.

Resources Provided:

Date added: October 30, 2024